American pharmaceutical company, Johnson & Johnson have announced the opening of a new regional office in Nairobi as well as offices in Accra and Ghana.
The development represents a novel approach to how Johnson & Johnson seeks to develop partnerships, products and service delivery models that address neglected and emerging health issues. Teams from the company’s consumer, medical device, pharmaceutical, global public health and Global Community Impact (GCI) groups will be located in a central office in each country, helping to bring an integrated approach to improving health outcomes in the region.
“The expansion of our companies’ operations in Africa allows Johnson & Johnson to continue to build innovative, collaborative opportunities that meet a variety of market needs, including developing new pharmaceutical products, service delivery approaches and advocacy for health issues impacting vulnerable communities,” said Alma Scott, Head of Africa Operations and Partnerships, Global Public Health. “Through regional engagement with health delivery partners, we seek to support locally-executable programs that drive health impact.”